Breaking News Instant updates and real-time market news.

SAFE

Safehold

$85.39 /

+0.53 (+0.62%)

07:33
07/22/21
07/22
07:33
07/22/21
07:33

Safehold reports Q2 EPS 28c, consensus 33c

Reports Q2 revenue $44.2M, consensus $45.57M. "During Q2, Safehold grew its portfolio by over $200M, while innovatively expanding its suite of products to capture pre-development opportunities," said CEO Jay Sugarman. "With ample liquidity on hand, a robust pipeline, and a lower cost of capital, Safehold is well positioned to continue to drive growth and deliver modern ground lease capital to a broader customer base."

  • 22

    Jul

  • 17

    Aug

  • 11

    Nov

SAFE Safehold
$85.39 /

+0.53 (+0.62%)

06/23/21
Fly Intel: Top five analyst initiations
06/23/21 B. Riley
Safehold initiated with a Buy, $100 target at B. Riley
06/22/21 B. Riley
Safehold initiated with a Buy at B. Riley
03/30/21 Goldman Sachs
Safehold price target lowered to $95 from $112 at Goldman Sachs

TODAY'S FREE FLY STORIES

Hot Stocks
Dana and Switch Mobility partner on electrified commercial vehicles » 21:01
07/29/21
07/29
21:01
07/29/21
21:01
DAN

Dana

$23.88 /

+0.81 (+3.51%)

Dana and Switch Mobility…

Dana and Switch Mobility announced the signing of a strategic agreement between the two entities. Under the terms of the agreement, Dana will make a strategic investment in Switch Mobility and become a preferred supplier of electric drivetrain components for the company's e-bus and EV commercial vehicle offering, providing e-Axles, gearboxes, motors, inverters, software and controls, and electronics cooling.

ShowHide Related Items >><<
DAN Dana
$23.88 /

+0.81 (+3.51%)

DAN Dana
$23.88 /

+0.81 (+3.51%)

07/15/21 Deutsche Bank
Dana price target lowered to $33 from $34 at Deutsche Bank
04/15/21 Barclays
Barclays shuffles ratings in Auto Parts into 'summer recovery'
04/09/21 Barclays
Dana upgraded to Overweight on electrification benefits at Barclays
04/09/21 Barclays
Dana upgraded to Overweight from Equal Weight at Barclays
DAN Dana
$23.88 /

+0.81 (+3.51%)

Upgrade
UniCredit upgraded to Outperform from Neutral at Exane BNP Paribas » 20:39
07/29/21
07/29
20:39
07/29/21
20:39
UNCRY

UniCredit

$5.84 /

+0.14 (+2.46%)

Exane BNP Paribas analyst…

Exane BNP Paribas analyst Andrea Vercellone upgraded UniCredit to Outperform from Neutral with a price target of EUR 12.7, up from EUR 11.4. Risks related to the company's acquisition of Banca Monte Paschi are "largely off the table" as Unicredit has entered into exclusive negotiation with the Italian treasury to participate in the deal under a strict set of conditions, the analyst tells investors in a research note.

ShowHide Related Items >><<
UNCRY UniCredit
$5.84 /

+0.14 (+2.46%)

07/16/21 JPMorgan
UniCredit price target lowered to EUR 11 from EUR 11.50 at JPMorgan
06/10/21 Erste Group
UniCredit upgraded to Hold from Sell at Erste Group
05/10/21 JPMorgan
UniCredit price target raised to EUR 11 from EUR 10 at JPMorgan
05/10/21 UBS
UniCredit price target raised to EUR 12.40 from EUR 11.70 at UBS
UNCRY UniCredit
$5.84 /

+0.14 (+2.46%)

UNCRY UniCredit
$5.84 /

+0.14 (+2.46%)

Earnings
Notable companies reporting before tomorrow's open » 20:25
07/29/21
07/29
20:25
07/29/21
20:25
PG

Procter & Gamble

$139.37 /

+0.6 (+0.43%)

, XOM

Exxon Mobil

$58.91 /

+0.7 (+1.20%)

, ABBV

AbbVie

$118.89 /

+0.14 (+0.12%)

, CVX

Chevron

$102.54 /

+1.32 (+1.30%)

, CHTR

Charter

$712.71 /

-10.03 (-1.39%)

, CAT

Caterpillar

$212.63 /

+1.1 (+0.52%)

, CL

Colgate-Palmolive

$83.49 /

+0.315 (+0.38%)

, VFC

VF Corp.

$84.54 /

+1.715 (+2.07%)

, QSR

Restaurant Brands

$64.91 /

+0.57 (+0.89%)

, CERN

Cerner

$78.49 /

-0.26 (-0.33%)

, NWL

Newell Brands

$27.23 /

+0.395 (+1.47%)

Notable companies…

Notable companies reporting before tomorrow's open, with earnings consensus, include Procter & Gamble (PG), consensus $1.09... Exxon Mobil (XOM), consensus 97c... AbbVie (ABBV), consensus $3.09... Chevron (CVX), consensus $1.50... Charter (CHTR), consensus $4.78... Caterpillar (CAT), consensus $2.38... Colgate-Palmolive (CL), consensus 80c... V.F. Corp. (VFC), consensus 10c... Restaurant Brands (QSR), consensus 56c... Cerner (CERN), consensus 76c... Newell Brands (NWL), consensus 45c.

ShowHide Related Items >><<
XOM Exxon Mobil
$58.91 /

+0.7 (+1.20%)

VFC VF Corp.
$84.54 /

+1.715 (+2.07%)

QSR Restaurant Brands
$64.91 /

+0.57 (+0.89%)

PG Procter & Gamble
$139.37 /

+0.6 (+0.43%)

NWL Newell Brands
$27.23 /

+0.395 (+1.47%)

CVX Chevron
$102.54 /

+1.32 (+1.30%)

CL Colgate-Palmolive
$83.49 /

+0.315 (+0.38%)

CHTR Charter
$712.71 /

-10.03 (-1.39%)

CERN Cerner
$78.49 /

-0.26 (-0.33%)

CAT Caterpillar
$212.63 /

+1.1 (+0.52%)

ABBV AbbVie
$118.89 /

+0.14 (+0.12%)

PG Procter & Gamble
$139.37 /

+0.6 (+0.43%)

06/23/21 UBS
Procter & Gamble initiated with a Neutral at UBS
04/21/21
Fly Intel: Top five analyst downgrades
04/21/21 Roth Capital
PureCycle Technologies initiated with a Buy at Roth Capital
04/21/21 Citi
Procter & Gamble downgraded to Neutral from Buy at Citi
XOM Exxon Mobil
$58.91 /

+0.7 (+1.20%)

07/23/21 Piper Sandler
Exxon Mobil price target raised to $69 from $63 at Piper Sandler
07/22/21 HSBC
Exxon Mobil price target lowered to $57 from $65 at HSBC
07/12/21
Fly Intel: Top five analyst initiations
07/12/21 BMO Capital
Exxon Mobil initiated with a Market Perform at BMO Capital
ABBV AbbVie
$118.89 /

+0.14 (+0.12%)

07/26/21 Truist
AbbVie assumed with a Buy at Truist
07/26/21 Truist
AbbVie assumed with a Buy at Truist
07/02/21
Fly Intel: Top five analyst initiations
07/02/21 Daiwa
AbbVie initiated with an Outperform at Daiwa
CVX Chevron
$102.54 /

+1.32 (+1.30%)

07/23/21 Piper Sandler
Chevron price target raised to $137 from $126 at Piper Sandler
07/22/21
Fly Intel: Top five analyst downgrades
07/22/21 Redburn
Chevron upgraded to Buy from Neutral at Redburn
07/22/21 HSBC
Chevron downgraded to Hold from Buy at HSBC
CHTR Charter
$712.71 /

-10.03 (-1.39%)

07/20/21 Craig-Hallum
Craig-Hallum bullish on Orbital Energy after Charter's rural broadband award
07/20/21 Morgan Stanley
Charter price target raised to $800 from $750 at Morgan Stanley
07/12/21
Fly Intel: Top five analyst downgrades
07/12/21 Bernstein
Charter downgraded to Market Perform from Outperform at Bernstein
CAT Caterpillar
$212.63 /

+1.1 (+0.52%)

07/14/21 Deutsche Bank
Caterpillar price target lowered to $258 from $273 at Deutsche Bank
07/14/21 OTR Global
Caterpillar downgraded to Mixed from Positive at OTR Global
07/13/21 JPMorgan
JPMorgan sees opportunities in machinery, upgrades three to Overweight
06/04/21 Deutsche Bank
Caterpillar price target raised to $273 from $259 at Deutsche Bank
CL Colgate-Palmolive
$83.49 /

+0.315 (+0.38%)

06/23/21 UBS
Colgate-Palmolive initiated with a Buy at UBS
06/09/21
Fly Intel: Top five analyst upgrades
06/09/21 Credit Suisse
Colgate-Palmolive upgraded to Outperform from Neutral at Credit Suisse
05/03/21 Deutsche Bank
Colgate-Palmolive price target raised to $85 from $84 at Deutsche Bank
VFC VF Corp.
$84.54 /

+1.715 (+2.07%)

07/15/21 Deutsche Bank
VF Corp. price target raised to $101 from $98 at Deutsche Bank
07/14/21 Goldman Sachs
VF Corp. initiated with a Sell at Goldman Sachs
05/24/21 JPMorgan
VF Corp. price target raised to $106 from $104 at JPMorgan
05/24/21 Baird
VF Corp. current levels provide compelling entry point, says Baird
QSR Restaurant Brands
$64.91 /

+0.57 (+0.89%)

07/26/21 Guggenheim
Guggenheim says Tim Horton's saturation weighing on Restaurant Brands
07/26/21 Guggenheim
Restaurant Brands initiated with a Neutral at Guggenheim
06/01/21 Barclays
Restaurant Brands price target raised to $77 from $73 at Barclays
05/06/21
Fly Intel: Top five analyst upgrades
CERN Cerner
$78.49 /

-0.26 (-0.33%)

04/29/21 JPMorgan
Cerner assumed with a Neutral at JPMorgan
02/16/21 Piper Sandler
Cerner price target raised to $85 from $84 at Piper Sandler
02/11/21 KeyBanc
Cerner price target raised to $90 from $82 at KeyBanc
02/11/21 Truist
Cerner price target raised to $82 from $72 at Truist
NWL Newell Brands
$27.23 /

+0.395 (+1.47%)

07/14/21 Raymond James
Newell Brands upgraded to Strong Buy from Market Perform at Raymond James
07/13/21 Raymond James
Newell Brands upgraded to Strong Buy from Market Perform at Raymond James
06/23/21 UBS
Newell Brands initiated with a Buy at UBS
05/03/21 Truist
Newell Brands price target raised to $35 from $30 at Truist
XOM Exxon Mobil
$58.91 /

+0.7 (+1.20%)

VFC VF Corp.
$84.54 /

+1.715 (+2.07%)

QSR Restaurant Brands
$64.91 /

+0.57 (+0.89%)

PG Procter & Gamble
$139.37 /

+0.6 (+0.43%)

NWL Newell Brands
$27.23 /

+0.395 (+1.47%)

CVX Chevron
$102.54 /

+1.32 (+1.30%)

CL Colgate-Palmolive
$83.49 /

+0.315 (+0.38%)

CHTR Charter
$712.71 /

-10.03 (-1.39%)

CERN Cerner
$78.49 /

-0.26 (-0.33%)

CAT Caterpillar
$212.63 /

+1.1 (+0.52%)

ABBV AbbVie
$118.89 /

+0.14 (+0.12%)

XOM Exxon Mobil
$58.91 /

+0.7 (+1.20%)

QSR Restaurant Brands
$64.91 /

+0.57 (+0.89%)

PG Procter & Gamble
$139.37 /

+0.6 (+0.43%)

CVX Chevron
$102.54 /

+1.32 (+1.30%)

CL Colgate-Palmolive
$83.49 /

+0.315 (+0.38%)

CHTR Charter
$712.71 /

-10.03 (-1.39%)

CERN Cerner
$78.49 /

-0.26 (-0.33%)

CAT Caterpillar
$212.63 /

+1.1 (+0.52%)

ABBV AbbVie
$118.89 /

+0.14 (+0.12%)

XOM Exxon Mobil
$58.91 /

+0.7 (+1.20%)

VFC VF Corp.
$84.54 /

+1.715 (+2.07%)

QSR Restaurant Brands
$64.91 /

+0.57 (+0.89%)

PG Procter & Gamble
$139.37 /

+0.6 (+0.43%)

NWL Newell Brands
$27.23 /

+0.395 (+1.47%)

CVX Chevron
$102.54 /

+1.32 (+1.30%)

CHTR Charter
$712.71 /

-10.03 (-1.39%)

CERN Cerner
$78.49 /

-0.26 (-0.33%)

CAT Caterpillar
$212.63 /

+1.1 (+0.52%)

ABBV AbbVie
$118.89 /

+0.14 (+0.12%)

XOM Exxon Mobil
$58.91 /

+0.7 (+1.20%)

VFC VF Corp.
$84.54 /

+1.715 (+2.07%)

PG Procter & Gamble
$139.37 /

+0.6 (+0.43%)

NWL Newell Brands
$27.23 /

+0.395 (+1.47%)

CVX Chevron
$102.54 /

+1.32 (+1.30%)

CL Colgate-Palmolive
$83.49 /

+0.315 (+0.38%)

CAT Caterpillar
$212.63 /

+1.1 (+0.52%)

ABBV AbbVie
$118.89 /

+0.14 (+0.12%)

Hot Stocks
BeiGene says phase 3 trial of BRUKINSA in CLL treatment met primary endpoint » 20:03
07/29/21
07/29
20:03
07/29/21
20:03
BGNE

BeiGene

$312.21 /

-1.19 (-0.38%)

The company states:…

The company states: "BeiGene announced positive topline results from an interim analysis of the Phase 3 SEQUOIA trial comparing BRUKINSA to bendamustine and rituximab in patients with treatment-naive chronic lymphocytic leukemia, or CLL, or small lymphocytic lymphoma, or SLL, whose tumor did not exhibit the deletion of chromosome 17p13.1. With a median follow-up of 25.8 months, the SEQUOIA trial met the primary endpoint of progression-free survival as assessed by independent review committee, as BRUKINSA achieved a highly statistically significant improvement in PFS compared to B+R. In addition, the trial demonstrated a statistically significant improvement in PFS per investigator assessment, a secondary endpoint. BRUKINSA was also generally well-tolerated, consistent with its known safety profile."

ShowHide Related Items >><<
BGNE BeiGene
$312.21 /

-1.19 (-0.38%)

BGNE BeiGene
$312.21 /

-1.19 (-0.38%)

06/14/21 SVB Leerink
BeiGene price target raised to $417 from $388 at SVB Leerink
03/16/21 HSBC
BeiGene price target raised to $385 from $296 at HSBC
03/08/21 China Renaissance
BeiGene initiated with a Buy at China Renaissance
03/04/21 Goldman Sachs
Five Prime acquisition 'a strategic positive' for Amgen, says Goldman Sachs
BGNE BeiGene
$312.21 /

-1.19 (-0.38%)

  • 02
    Dec
Periodicals
Dole prices IPO at $16, low end of $16-$17 range, Bloomberg says  19:36
07/29/21
07/29
19:36
07/29/21
19:36
DOLE

Dole

/

+

 
ShowHide Related Items >><<
  • 30
    Jul
Earnings
SJW Group backs FY21 EPS view of $1.85-$2.05, consensus $2.02  19:32
07/29/21
07/29
19:32
07/29/21
19:32
SJW

SJW Group

$69.00 /

+1.1 (+1.62%)

 
ShowHide Related Items >><<
SJW SJW Group
$69.00 /

+1.1 (+1.62%)

SJW SJW Group
$69.00 /

+1.1 (+1.62%)

07/15/21
Fly Intel: Top five analyst initiations
07/15/21 Barclays
SJW Group initiated with an Equal Weight at Barclays
04/16/21 Seaport Global
California Water Service downgraded to Sell from Neutral at Seaport Global
01/06/21 Wells Fargo
Wells Fargo says buy CenterPoint Energy, sell FirstEnergy
SJW SJW Group
$69.00 /

+1.1 (+1.62%)

  • 09
    Mar
SJW SJW Group
$69.00 /

+1.1 (+1.62%)

Earnings
SJW Group reports Q2 EPS 79c, consensus 65c » 19:32
07/29/21
07/29
19:32
07/29/21
19:32
SJW

SJW Group

$69.00 /

+1.1 (+1.62%)

Reports Q2 revenue…

Reports Q2 revenue $152.2M, consensus $154.5M.

ShowHide Related Items >><<
SJW SJW Group
$69.00 /

+1.1 (+1.62%)

SJW SJW Group
$69.00 /

+1.1 (+1.62%)

07/15/21
Fly Intel: Top five analyst initiations
07/15/21 Barclays
SJW Group initiated with an Equal Weight at Barclays
04/16/21 Seaport Global
California Water Service downgraded to Sell from Neutral at Seaport Global
01/06/21 Wells Fargo
Wells Fargo says buy CenterPoint Energy, sell FirstEnergy
SJW SJW Group
$69.00 /

+1.1 (+1.62%)

  • 09
    Mar
SJW SJW Group
$69.00 /

+1.1 (+1.62%)

On The Fly
Fly Intel: After-Hours Movers » 18:57
07/29/21
07/29
18:57
07/29/21
18:57
TEAM

Atlassian

$266.79 /

-2.25 (-0.84%)

, QUMU

Qumu

$2.42 /

-0.16 (-6.20%)

, VCYT

Veracyte

$39.46 /

+0.05 (+0.13%)

, CC

Chemours

$32.92 /

+0.3 (+0.92%)

, MMSI

Merit Medical

$65.75 /

+0.62 (+0.95%)

, MITK

Mitek Systems

$19.51 /

+0.23 (+1.19%)

, KLAC

KLA Corp.

$319.12 /

+3.2 (+1.01%)

, ERYP

Erytech Pharma

$4.17 /

-0.1 (-2.34%)

, MSON

Misonix

$23.77 /

-0.2 (-0.83%)

, PINS

Pinterest

$71.83 /

-4.91 (-6.40%)

, DV

DoubleVerify

$35.76 /

+0.865 (+2.48%)

, ZYXI

Zynex

$16.75 /

-0.47 (-2.73%)

, POLY

Poly

$32.78 /

-0.1 (-0.30%)

, AMZN

Amazon.com

$3,599.22 /

-33.28 (-0.92%)

, TXRH

Texas Roadhouse

$98.68 /

-0.16 (-0.16%)

, SWKS

Skyworks

$196.78 /

+4.58 (+2.38%)

, ZEN

Zendesk

$150.72 /

-0.34 (-0.23%)

, LLNW

Limelight Networks

$2.66 /

+0.03 (+1.14%)

, UPWK

Upwork

$57.47 /

-0.57 (-0.98%)

, ROG

Rogers Corporation

$203.74 /

+2.25 (+1.12%)

, KMPR

Kemper

$68.36 /

+0.47 (+0.69%)

, FTNT

Fortinet

$274.05 /

+2.36 (+0.87%)

, TWOU

2U

$46.15 /

+0.26 (+0.57%)

, GILD

Gilead

$69.83 /

-0.28 (-0.40%)

, FSLR

First Solar

$83.75 /

+0.26 (+0.31%)

Check out this evening's…

ShowHide Related Items >><<
ZYXI Zynex
$16.75 /

-0.47 (-2.73%)

ZEN Zendesk
$150.72 /

-0.34 (-0.23%)

VCYT Veracyte
$39.46 /

+0.05 (+0.13%)

UPWK Upwork
$57.47 /

-0.57 (-0.98%)

TXRH Texas Roadhouse
$98.68 /

-0.16 (-0.16%)

TWOU 2U
$46.15 /

+0.26 (+0.57%)

TEAM Atlassian
$266.79 /

-2.25 (-0.84%)

SWKS Skyworks
$196.78 /

+4.58 (+2.38%)

ROG Rogers Corporation
$203.74 /

+2.25 (+1.12%)

QUMU Qumu
$2.42 /

-0.16 (-6.20%)

POLY Poly
$32.78 /

-0.1 (-0.30%)

PINS Pinterest
$71.83 /

-4.91 (-6.40%)

MSON Misonix
$23.77 /

-0.2 (-0.83%)

MMSI Merit Medical
$65.75 /

+0.62 (+0.95%)

MITK Mitek Systems
$19.51 /

+0.23 (+1.19%)

LLNW Limelight Networks
$2.66 /

+0.03 (+1.14%)

KMPR Kemper
$68.36 /

+0.47 (+0.69%)

KLAC KLA Corp.
$319.12 /

+3.2 (+1.01%)

GILD Gilead
$69.83 /

-0.28 (-0.40%)

FTNT Fortinet
$274.05 /

+2.36 (+0.87%)

FSLR First Solar
$83.75 /

+0.26 (+0.31%)

ERYP Erytech Pharma
$4.17 /

-0.1 (-2.34%)

DV DoubleVerify
$35.76 /

+0.865 (+2.48%)

CC Chemours
$32.92 /

+0.3 (+0.92%)

AMZN Amazon.com
$3,599.22 /

-33.28 (-0.92%)

TEAM Atlassian
$266.79 /

-2.25 (-0.84%)

07/22/21
Fly Intel: Top five analyst downgrades
07/22/21 Cowen
Cowen downgrades Atlassian on valuation, model transition
07/22/21 Cowen
Atlassian downgraded to Market Perform from Outperform at Cowen
07/16/21 Mizuho
Atlassian price target raised to $310 from $285 at Mizuho
QUMU Qumu
$2.42 /

-0.16 (-6.20%)

06/11/21
Fly Intel: Top five analyst downgrades
06/11/21 Craig-Hallum
Qumu downgraded to Hold from Buy at Craig-Hallum
06/11/21 Craig-Hallum
Qumu downgraded to Hold from Buy at Craig-Hallum
02/12/21 Lake Street
Synacor downgraded to Hold from Buy at Lake Street
VCYT Veracyte
$39.46 /

+0.05 (+0.13%)

06/28/21 Raymond James
Veracyte price target raised to $50 from $45 at Raymond James
06/15/21 Raymond James
Veracyte initiated with an Outperform at Raymond James
06/15/21 Raymond James
Veracyte initiated with an Outperform at Raymond James
06/03/21 Goldman Sachs
Veracyte initiated with Not Rated at Goldman Sachs
CC Chemours
$32.92 /

+0.3 (+0.92%)

06/30/21 BMO Capital
Chemours price target raised to $48 from $42 at BMO Capital
06/09/21 Wolfe Research
Chemours initiated with an Outperform at Wolfe Research
06/09/21
Fly Intel: Top five analyst upgrades
06/09/21 Goldman Sachs
Chemours upgraded to Buy from Neutral at Goldman Sachs
MMSI Merit Medical
$65.75 /

+0.62 (+0.95%)

05/17/21 Barrington
Merit Medical will be $100 stock within 3-5 years, says Barrington
04/30/21 Barrington
Merit Medical price target raised to $71 from $63 at Barrington
02/26/21 Canaccord
Merit Medical price target raised to $71 from $55 at Canaccord
02/25/21 Barrington
Merit Medical price target raised to $63 from $62 at Barrington
MITK Mitek Systems
$19.51 /

+0.23 (+1.19%)

06/30/21 Benchmark
Mitek check fraud product announcement 'important news,' says Benchmark
04/16/21 Jefferies
Mitek Systems initiated with a Buy at Jefferies
01/22/21 Maxim
Mitek Systems initiated with a Buy at Maxim
12/04/20 Benchmark
Mitek Systems CFO exit plan adds uncertainty, says Benchmark
KLAC KLA Corp.
$319.12 /

+3.2 (+1.01%)

06/09/21 Deutsche Bank
KLA Corp. upgraded to Buy from Hold at Deutsche Bank
05/04/21 Stifel
Intel spending plans show new CEO 'gets it,' says Stifel
04/27/21 Credit Suisse
KLA Corp. price target raised to $380 from $325 at Credit Suisse
ERYP Erytech Pharma
$4.17 /

-0.1 (-2.34%)

MSON Misonix
$23.77 /

-0.2 (-0.83%)

05/25/21 Canaccord
Misonix COVID impact while Nexus remains strong, says Canaccord
PINS Pinterest
$71.83 /

-4.91 (-6.40%)

07/23/21 Morgan Stanley
Snap price target raised to $85 from $75 at Morgan Stanley
05/10/21 Arete
Pinterest initiated with a Buy at Arete
05/10/21 Citi
Pinterest price target lowered to $65 from $85 at Citi
04/30/21 MKM Partners
Twitter price target lowered to $83 from $95 at MKM Partners
DV DoubleVerify
$35.76 /

+0.865 (+2.48%)

07/26/21 Wells Fargo
Integral Ad Science initiated with an Overweight at Wells Fargo
05/26/21 Truist
DoubleVerify price target raised to $34 from $30 at Truist
05/26/21 Canaccord
DoubleVerify price target raised to $44 from $40 at Canaccord
05/26/21 RBC Capital
DoubleVerify price target raised to $40 from $37 at RBC Capital
ZYXI Zynex
$16.75 /

-0.47 (-2.73%)

07/16/21 B. Riley
Zynex upgraded to Buy into 'accelerating trends' at B. Riley
07/16/21 B. Riley
Zynex upgraded to Buy from Neutral at B. Riley
07/15/21 Piper Sandler
Piper Sandler remains on the sidelines after Zynex preliminary quarterly results
04/29/21 Piper Sandler
Zynex price target lowered to $15 from $19 at Piper Sandler
POLY Poly
$32.78 /

-0.1 (-0.30%)

07/06/21 Morgan Stanley
Poly price target raised to $37 from $31 at Morgan Stanley
AMZN Amazon.com
$3,599.22 /

-33.28 (-0.92%)

07/28/21 Wedbush
Alphabet price target raised to $3,424 from $3,127 at Wedbush
07/27/21 KeyBanc
Workday HCM rollout termination at Amazon not a competitive loss, says KeyBanc
07/26/21 Credit Suisse
Amazon.com price target raised to $4,850 from $4,000 at Credit Suisse
07/26/21 Wedbush
Wedbush expects 'Amazon-sized' tailwinds from Prime Day, COVID-19
TXRH Texas Roadhouse
$98.68 /

-0.16 (-0.16%)

07/20/21 Wells Fargo
Texas Roadhouse price target lowered to $99 from $107 at Wells Fargo
06/09/21 Stephens
Texas Roadhouse price target lowered to $105 from $110 at Stephens
06/09/21 Truist
Texas Roadhouse price target raised to $127 from $124 at Truist
06/01/21 Barclays
Texas Roadhouse price target lowered to $111 from $119 at Barclays
SWKS Skyworks
$196.78 /

+4.58 (+2.38%)

07/28/21 KeyBanc
Apple results moderately positive for iPhone suppliers, says KeyBanc
07/15/21 WestPark Capital
Skyworks initiated with a Buy at WestPark Capital
07/06/21 KeyBanc
Skyworks price target raised to $225 from $220 at KeyBanc
06/29/21 Citi
Citi opens 'positive catalyst watch' on Skyworks
ZEN Zendesk
$150.72 /

-0.34 (-0.23%)

05/27/21
Fly Intel: Top five analyst upgrades
05/27/21 UBS
Zendesk upgraded to Buy from Neutral at UBS
04/30/21 Piper Sandler
Zendesk price target raised to $186 from $180 at Piper Sandler
04/22/21 Wolfe Research
Zendesk initiated with an Outperform at Wolfe Research
LLNW Limelight Networks
$2.66 /

+0.03 (+1.14%)

07/06/21 Goldman Sachs
Limelight Networks downgraded to Sell from Neutral at Goldman Sachs
06/10/21 Lake Street
Limelight Networks still trades at 'too great a discount,' says Lake Street
03/19/21 DA Davidson
Limelight Networks price target lowered to $2.75 from $3.00 at DA Davidson
02/12/21 Lake Street
Limelight Networks price target lowered to $6 from $9 at Lake Street
UPWK Upwork
$57.47 /

-0.57 (-0.98%)

07/01/21 BTIG
Upwork price target raised to $76 from $65 at BTIG
05/05/21 BTIG
Upwork price target lowered to $65 from $75 at BTIG
02/25/21 Citi
Upwork price target raised to $75 from $48 at Citi
02/24/21 MKM Partners
Upwork price target raised to $69 from $52 at MKM Partners
ROG Rogers Corporation
$203.74 /

+2.25 (+1.12%)

06/09/21 Wolfe Research
Rogers Corporation initiated with an Outperform at Wolfe Research
05/26/21
Fly Intel: Top five analyst initiations
05/26/21 Canaccord
Canaccord starts Rogers with Buy on electrification benefits
05/26/21 Canaccord
Rogers Corporation initiated with a Buy at Canaccord
KMPR Kemper
$68.36 /

+0.47 (+0.69%)

07/19/21
Fly Intel: Top five analyst downgrades
07/19/21 Raymond James
Kemper downgraded to Market Perform from Strong Buy at Raymond James
03/11/21 Raymond James
Kemper price target raised to $95 from $85 at Raymond James
10/19/20 Raymond James
Kemper price target lowered to $85 from $95 at Raymond James
FTNT Fortinet
$274.05 /

+2.36 (+0.87%)

07/22/21 Cowen
Fortinet price target raised to $305 from $270 at Cowen
07/22/21 KeyBanc
Fortinet price target raised to $297 from $240 at KeyBanc
07/20/21 BTIG
Fortinet price target raised to $291 from $240 at BTIG
07/19/21 Raymond James
Fortinet price target raised to $280 from $225 at Raymond James
TWOU 2U
$46.15 /

+0.26 (+0.57%)

07/12/21 Macquarie
2U upgraded to Outperform from Neutral at Macquarie
06/29/21 Jefferies
Jefferies gives a 'thumbs up' to 2U acquisition of edX
05/18/21 Jefferies
2U price target lowered to $50 from $60 at Jefferies
04/29/21 Morgan Stanley
2U price target lowered to $53 from $55 at Morgan Stanley
GILD Gilead
$69.83 /

-0.28 (-0.40%)

06/29/21 Jefferies
Gilead data should move Yescarta up to second line in DLBCL, says Jefferies
06/16/21 Roth Capital
JTX-1811 IND-clearance further validates Jounce platform, says Roth Capital
06/15/21 Piper Sandler
Jounce Therapeutics receives $25M milestone from Gilead, says Piper Sandler
04/01/21
Fly Intel: Top five analyst upgrades
FSLR First Solar
$83.75 /

+0.26 (+0.31%)

07/21/21 JPMorgan
First Solar price target raised to $101 from $94 at JPMorgan
07/15/21 Piper Sandler
First Solar price target lowered to $80 from $81 at Piper Sandler
07/13/21 Credit Suisse
First Solar assumed with a Neutral at Credit Suisse
07/13/21
Fly Intel: Top five analyst downgrades
ZYXI Zynex
$16.75 /

-0.47 (-2.73%)

ZEN Zendesk
$150.72 /

-0.34 (-0.23%)

VCYT Veracyte
$39.46 /

+0.05 (+0.13%)

UPWK Upwork
$57.47 /

-0.57 (-0.98%)

TXRH Texas Roadhouse
$98.68 /

-0.16 (-0.16%)

TWOU 2U
$46.15 /

+0.26 (+0.57%)

TEAM Atlassian
$266.79 /

-2.25 (-0.84%)

SWKS Skyworks
$196.78 /

+4.58 (+2.38%)

ROG Rogers Corporation
$203.74 /

+2.25 (+1.12%)

QUMU Qumu
$2.42 /

-0.16 (-6.20%)

POLY Poly
$32.78 /

-0.1 (-0.30%)

PINS Pinterest
$71.83 /

-4.91 (-6.40%)

MSON Misonix
$23.77 /

-0.2 (-0.83%)

MMSI Merit Medical
$65.75 /

+0.62 (+0.95%)

MITK Mitek Systems
$19.51 /

+0.23 (+1.19%)

LLNW Limelight Networks
$2.66 /

+0.03 (+1.14%)

KMPR Kemper
$68.36 /

+0.47 (+0.69%)

KLAC KLA Corp.
$319.12 /

+3.2 (+1.01%)

GILD Gilead
$69.83 /

-0.28 (-0.40%)

FTNT Fortinet
$274.05 /

+2.36 (+0.87%)

FSLR First Solar
$83.75 /

+0.26 (+0.31%)

DV DoubleVerify
$35.76 /

+0.865 (+2.48%)

CC Chemours
$32.92 /

+0.3 (+0.92%)

AMZN Amazon.com
$3,599.22 /

-33.28 (-0.92%)

  • 21
    Apr
  • 05
    Feb
  • 27
    Jan
  • 15
    Dec
  • 17
    Sep
  • 06
    Aug
  • 05
    Aug
UPWK Upwork
$57.47 /

-0.57 (-0.98%)

PINS Pinterest
$71.83 /

-4.91 (-6.40%)

GILD Gilead
$69.83 /

-0.28 (-0.40%)

FTNT Fortinet
$274.05 /

+2.36 (+0.87%)

FSLR First Solar
$83.75 /

+0.26 (+0.31%)

AMZN Amazon.com
$3,599.22 /

-33.28 (-0.92%)

ZYXI Zynex
$16.75 /

-0.47 (-2.73%)

VCYT Veracyte
$39.46 /

+0.05 (+0.13%)

UPWK Upwork
$57.47 /

-0.57 (-0.98%)

TXRH Texas Roadhouse
$98.68 /

-0.16 (-0.16%)

TWOU 2U
$46.15 /

+0.26 (+0.57%)

TEAM Atlassian
$266.79 /

-2.25 (-0.84%)

SWKS Skyworks
$196.78 /

+4.58 (+2.38%)

QUMU Qumu
$2.42 /

-0.16 (-6.20%)

PINS Pinterest
$71.83 /

-4.91 (-6.40%)

MSON Misonix
$23.77 /

-0.2 (-0.83%)

MITK Mitek Systems
$19.51 /

+0.23 (+1.19%)

LLNW Limelight Networks
$2.66 /

+0.03 (+1.14%)

GILD Gilead
$69.83 /

-0.28 (-0.40%)

FSLR First Solar
$83.75 /

+0.26 (+0.31%)

ERYP Erytech Pharma
$4.17 /

-0.1 (-2.34%)

DV DoubleVerify
$35.76 /

+0.865 (+2.48%)

CC Chemours
$32.92 /

+0.3 (+0.92%)

AMZN Amazon.com
$3,599.22 /

-33.28 (-0.92%)

ZYXI Zynex
$16.75 /

-0.47 (-2.73%)

UPWK Upwork
$57.47 /

-0.57 (-0.98%)

TEAM Atlassian
$266.79 /

-2.25 (-0.84%)

SWKS Skyworks
$196.78 /

+4.58 (+2.38%)

POLY Poly
$32.78 /

-0.1 (-0.30%)

PINS Pinterest
$71.83 /

-4.91 (-6.40%)

LLNW Limelight Networks
$2.66 /

+0.03 (+1.14%)

KLAC KLA Corp.
$319.12 /

+3.2 (+1.01%)

GILD Gilead
$69.83 /

-0.28 (-0.40%)

FSLR First Solar
$83.75 /

+0.26 (+0.31%)

DV DoubleVerify
$35.76 /

+0.865 (+2.48%)

CC Chemours
$32.92 /

+0.3 (+0.92%)

AMZN Amazon.com
$3,599.22 /

-33.28 (-0.92%)

Earnings
Zynex sees FY21 revenue $130.0M-$137.5M, consensus $139.6M » 18:49
07/29/21
07/29
18:49
07/29/21
18:49
ZYXI

Zynex

$16.75 /

-0.47 (-2.73%)

Sees FY21 adj. EBITDA…

Sees FY21 adj. EBITDA $16.5M-$21.5M. The company states: "The full year revenue estimate is on the lower end of previously provided guidance due to a very competitive job market and therefore fewer sales reps than expected."

ShowHide Related Items >><<
ZYXI Zynex
$16.75 /

-0.47 (-2.73%)

ZYXI Zynex
$16.75 /

-0.47 (-2.73%)

07/16/21 B. Riley
Zynex upgraded to Buy into 'accelerating trends' at B. Riley
07/16/21 B. Riley
Zynex upgraded to Buy from Neutral at B. Riley
07/15/21 Piper Sandler
Piper Sandler remains on the sidelines after Zynex preliminary quarterly results
04/29/21 Piper Sandler
Zynex price target lowered to $15 from $19 at Piper Sandler
ZYXI Zynex
$16.75 /

-0.47 (-2.73%)

ZYXI Zynex
$16.75 /

-0.47 (-2.73%)

ZYXI Zynex
$16.75 /

-0.47 (-2.73%)

Earnings
Zynex sees Q3 revenue $34.5M-$36.0M, consensus $38.4M » 18:48
07/29/21
07/29
18:48
07/29/21
18:48
ZYXI

Zynex

$16.75 /

-0.47 (-2.73%)

Sees Q3 adj. EBITDA…

Sees Q3 adj. EBITDA $5M-$6M.

ShowHide Related Items >><<
ZYXI Zynex
$16.75 /

-0.47 (-2.73%)

ZYXI Zynex
$16.75 /

-0.47 (-2.73%)

07/16/21 B. Riley
Zynex upgraded to Buy into 'accelerating trends' at B. Riley
07/16/21 B. Riley
Zynex upgraded to Buy from Neutral at B. Riley
07/15/21 Piper Sandler
Piper Sandler remains on the sidelines after Zynex preliminary quarterly results
04/29/21 Piper Sandler
Zynex price target lowered to $15 from $19 at Piper Sandler
ZYXI Zynex
$16.75 /

-0.47 (-2.73%)

ZYXI Zynex
$16.75 /

-0.47 (-2.73%)

ZYXI Zynex
$16.75 /

-0.47 (-2.73%)

Earnings
Zynex reports Q2 EPS 8c, consensus 6c » 18:47
07/29/21
07/29
18:47
07/29/21
18:47
ZYXI

Zynex

$16.75 /

-0.47 (-2.73%)

Reports Q2 revenue…

Reports Q2 revenue $31.0M, consensus $31.3M. CEO Thomas Sandgaard said: "I am excited about our order growth in the second quarter of 247% which will continue to drive increasing revenue in 2021 and 2022. In the second quarter, we posted revenue of $31.0 million, which is the highest quarterly revenue in the history of the Company and net income of $2.8 million. We continue to focus on sales rep productivity and average reps during the period decreased to approximately 450 due to trimming non-productive reps and slowed hiring due to a very competitive job market. We have increased the rate of hiring in Q3 and expect to be well over 500 reps by the end of the year. We continue to advocate for pain patients, and for physicians to prescribe our NexWave technology as the first line of defense in treating chronic and acute pain without side effects. We are dedicated to promoting our technology in an effort to remove patient addiction and other side effects from prescription opioids."

ShowHide Related Items >><<
ZYXI Zynex
$16.75 /

-0.47 (-2.73%)

ZYXI Zynex
$16.75 /

-0.47 (-2.73%)

07/16/21 B. Riley
Zynex upgraded to Buy into 'accelerating trends' at B. Riley
07/16/21 B. Riley
Zynex upgraded to Buy from Neutral at B. Riley
07/15/21 Piper Sandler
Piper Sandler remains on the sidelines after Zynex preliminary quarterly results
04/29/21 Piper Sandler
Zynex price target lowered to $15 from $19 at Piper Sandler
ZYXI Zynex
$16.75 /

-0.47 (-2.73%)

ZYXI Zynex
$16.75 /

-0.47 (-2.73%)

ZYXI Zynex
$16.75 /

-0.47 (-2.73%)

Hot Stocks
HCA Healthcare CIO sells 7,466 common shares » 18:37
07/29/21
07/29
18:37
07/29/21
18:37
HCA

HCA Healthcare

$247.79 /

+1.6 (+0.65%)

In a regulatory filing,…

In a regulatory filing, HCA Healthcare CIO P. Martin Paslick disclosed the sale of 7,466 common shares of the company on July 27 at a price of $250 per share.

ShowHide Related Items >><<
HCA HCA Healthcare
$247.79 /

+1.6 (+0.65%)

HCA HCA Healthcare
$247.79 /

+1.6 (+0.65%)

07/22/21 Barclays
HCA Healthcare price target raised to $275 from $225 at Barclays
07/21/21 Truist
HCA Healthcare price target raised to $290 from $260 at Truist
07/21/21 Credit Suisse
HCA Healthcare price target raised to $267 from $222 at Credit Suisse
07/21/21 Raymond James
HCA Healthcare price target raised to $290 from $225 at Raymond James
HCA HCA Healthcare
$247.79 /

+1.6 (+0.65%)

HCA HCA Healthcare
$247.79 /

+1.6 (+0.65%)

HCA HCA Healthcare
$247.79 /

+1.6 (+0.65%)

Hot Stocks
Robinhood CEO: Our mission is to democratize finance for all » 18:35
07/29/21
07/29
18:35
07/29/21
18:35
HOOD

Robinhood

$34.70 /

-3.3 (-8.68%)

In an interview on…

In an interview on CNBC's Mad Money, Vlad Tenev said Robinhood is building a long-term business so short-term moves are not a concern. "We feel very well positioned to continue delivering value to customers," he added. According to Tenev, the top value of the company is safety first, which implies compliance first. "We've made a lot of improvements on how we communicate about options. We're confident in our ability to execute on our product roadmap," he noted.

ShowHide Related Items >><<
HOOD Robinhood
$34.70 /

-3.3 (-8.68%)

HOOD Robinhood
$34.70 /

-3.3 (-8.68%)

07/29/21
Fly Intel: Top five analyst initiations
07/29/21 Atlantic Equities
Robinhood initiated with an Overweight at Atlantic Equities
  • 29
    Jul
HOOD Robinhood
$34.70 /

-3.3 (-8.68%)

HOOD Robinhood
$34.70 /

-3.3 (-8.68%)

Hot Stocks
Boeing, NASA postpone launch of Starliner space capsule » 18:29
07/29/21
07/29
18:29
07/29/21
18:29
BA

Boeing

$231.63 /

+0.05 (+0.02%)

NASA said that, in order…

NASA said that, in order to allow the International Space Station team time to continue working checkouts of the Nauka module and confirm the station is ready for Boeing's Starliner's arrival, NASA and Boeing have delayed the launch of the OFT-2 mission, which had been targeted for Friday, July 30. The launch team is assessing the next available opportunity. Reference Link

ShowHide Related Items >><<
BA Boeing
$231.63 /

+0.05 (+0.02%)

BA Boeing
$231.63 /

+0.05 (+0.02%)

07/29/21 Susquehanna
Boeing estimates raised following earnings beat at Susquehanna
07/14/21 Morgan Stanley
Boeing's 787 'minor headache' doesn't change thesis, says Morgan Stanley
07/13/21
Fly Intel: Top five analyst upgrades
07/13/21 Wolfe Research
Boeing upgraded to Peer Perform at Wolfe Research after United's big order
BA Boeing
$231.63 /

+0.05 (+0.02%)

BA Boeing
$231.63 /

+0.05 (+0.02%)

BA Boeing
$231.63 /

+0.05 (+0.02%)

BA Boeing
$231.63 /

+0.05 (+0.02%)

Hot Stocks
Lantheus announces first and only FDA-cleared PSMA Digital Application » 18:26
07/29/21
07/29
18:26
07/29/21
18:26
LNTH

Lantheus

$27.03 /

+0.01 (+0.04%)

The company states:…

The company states: "Lantheus Holding announced that its subsidiary, EXINI Diagnostics AB, was granted 510(k) clearance by the FDA for its digital application, aPROMISE. Clinicians will have the option to utilize aPROMISE with PYLARIFY to increase the efficiency and reproducibility of their PSMA PET/CT assessments. PYLARIFY was recently approved by the FDA and is the first and only commercially available PSMA-targeted PET imaging agent for prostate cancer. aPROMISE is an artificial intelligence-based, medical device software that uses a deep learning algorithm trained and validated across over 3,000 PSMA images to date, to allow healthcare professionals and researchers to perform quantitative assessment of PSMA PET/CT images in prostate cancer. The PROMISE criteria were developed by leading experts in prostate cancer imaging to standardize quantitative evaluation of prostate cancer lesions by location using prostate-specific membrane antigen (PSMA) PET/CT.1 aPROMISE facilitates rapid and robust quantification of prostate cancer lesions in anatomical context, enabling clinicians to make routine use in the clinic of a comprehensive, automated approach to patient evaluation. aPROMISE includes a solution for automated body segmentation and marking, quantifying and reporting suspicious lesions in their anatomical context. aPROMISE provides enhanced consistency in quantitative analysis and standardized reports and has demonstrated increased efficiency and reproducibility of clinicians' PSMA PET/CT image assessments."

ShowHide Related Items >><<
LNTH Lantheus
$27.03 /

+0.01 (+0.04%)

LNTH Lantheus
$27.03 /

+0.01 (+0.04%)

02/01/21
Fly Intel: Top five analyst initiations
02/01/21 SVB Leerink
SVB Leerink bullish on Lantheus, initiates with an Outperform
02/01/21 SVB Leerink
Lantheus initiated with an Outperform at SVB Leerink
12/29/20 Credit Suisse
Lantheus price target lowered to $14 from $16 at Credit Suisse
LNTH Lantheus
$27.03 /

+0.01 (+0.04%)

LNTH Lantheus
$27.03 /

+0.01 (+0.04%)

Earnings
Yamana Gold reports Q2 adjusted EPS 7c, consensus 2c » 18:23
07/29/21
07/29
18:23
07/29/21
18:23
AUY

Yamana Gold

$4.32 /

+0.06 (+1.41%)

Reports Q2 revenue…

Reports Q2 revenue $437.4M, one estimate $431.81M. Q2 gold equivalent ounce production was 241,341, including gold production of 217,402 ounces, and silver production of 1.63 million ounces. Jacobina and Canadian Malartic production reached all-time quarterly highs, with total production of 47,503 and 92,106 ounces of gold, respectively.

ShowHide Related Items >><<
AUY Yamana Gold
$4.32 /

+0.06 (+1.41%)

AUY Yamana Gold
$4.32 /

+0.06 (+1.41%)

07/16/21 National Bank
Yamana Gold price target lowered to C$7.50 from C$8 at National Bank
07/08/21 Berenberg
Yamana Gold price target raised to 560 GBp from 500 GBp at Berenberg
05/20/21 National Bank
Yamana Gold price target raised to C$8 from C$7.25 at National Bank
04/23/21 National Bank
Yamana Gold price target raised to C$7.25 from C$7 at National Bank
AUY Yamana Gold
$4.32 /

+0.06 (+1.41%)

AUY Yamana Gold
$4.32 /

+0.06 (+1.41%)

Hot Stocks
TransMedics gets FDA clearance of OCS lung solution » 18:21
07/29/21
07/29
18:21
07/29/21
18:21
TMDX

TransMedics

$29.17 /

+ (+0.00%)

The company states:…

The company states: "TransMedics announced FDA 510(k) clearance of its OCS(TM) Lung Solution for use in transplants using cold storage techniques. The solution, which is also cleared as a component of the company's OCS Lung System, is indicated for hypothermic flushing, storage and transportation of donor lungs for transplantation. The OCS Lung System is approved in the U.S. and the Company's OCS Heart System and OCS Liver System are currently under review by the FDA after receiving positive votes by the FDA's relevant advisory panels in April and July respectively."

ShowHide Related Items >><<
TMDX TransMedics
$29.17 /

+ (+0.00%)

TMDX TransMedics
$29.17 /

+ (+0.00%)

05/21/21 Canaccord
TransMedics potential FDA approval bode well for growth run, says Canaccord
04/07/21 Canaccord
TransMedics label likely more limited than expected, says Canaccord
03/29/21 Cowen
TransMedics price target raised to $49 from $44 at Cowen
03/15/21 Canaccord
TransMedics price target raised to $79 from $46 at Canaccord
TMDX TransMedics
$29.17 /

+ (+0.00%)

TMDX TransMedics
$29.17 /

+ (+0.00%)

Earnings
Professional Holding reports Q2 EPS 47c, consensus 40c » 18:17
07/29/21
07/29
18:17
07/29/21
18:17
PFHD

Professional Holding

$20.39 /

+0.4 (+2.00%)

"The Company had a…

"The Company had a strong quarter of asset and net income growth." said Daniel R. Sheehan, Chairman and CEO. "These results were a product of continued scale and noninterest income improvement."

ShowHide Related Items >><<
PFHD Professional Holding
$20.39 /

+0.4 (+2.00%)

PFHD Professional Holding
$20.39 /

+0.4 (+2.00%)

07/08/21 Raymond James
Professional Holding initiated with an Outperform at Raymond James
05/07/21 Keefe Bruyette
Professional Holding upgraded to Outperform at Keefe Bruyette
02/03/21 Stephens
Stephens upgrades Professional Holding to Overweight with Florida 'booming'
02/03/21 Stephens
Professional Holding upgraded to Overweight from Equal Weight at Stephens
PFHD Professional Holding
$20.39 /

+0.4 (+2.00%)

Hot Stocks
Yamana Gold making normal-course issuer bid for up to 5% of common shares » 18:14
07/29/21
07/29
18:14
07/29/21
18:14
AUY

Yamana Gold

$4.32 /

+0.06 (+1.41%)

Yamana Gold will make a…

Yamana Gold will make a normal-course issuer bid to purchase up to 48,321,676 common shares of the company representing up to 5% of the company's current issued and outstanding common shares, in open market transactions through the facilities of the TSX, the NYSE and alternative Canadian trading systems, subject to TSX approval. The company will be permitted to make purchases under the NCIB over a period of twelve months commencing on August 4 and expiring no later than August 3. Any daily purchases on the TSX under the NCIB are limited to a maximum of 654,276 common shares. Yamana will not acquire per day on the NYSE more than 25% of the average daily trading volume for the four calendar weeks preceding the date of purchase. Any common shares that are purchased under the NCIB will be cancelled.

ShowHide Related Items >><<
AUY Yamana Gold
$4.32 /

+0.06 (+1.41%)

AUY Yamana Gold
$4.32 /

+0.06 (+1.41%)

07/16/21 National Bank
Yamana Gold price target lowered to C$7.50 from C$8 at National Bank
07/08/21 Berenberg
Yamana Gold price target raised to 560 GBp from 500 GBp at Berenberg
05/20/21 National Bank
Yamana Gold price target raised to C$8 from C$7.25 at National Bank
04/23/21 National Bank
Yamana Gold price target raised to C$7.25 from C$7 at National Bank
AUY Yamana Gold
$4.32 /

+0.06 (+1.41%)

AUY Yamana Gold
$4.32 /

+0.06 (+1.41%)

Periodicals
United Airlines to outsource catering operations, Reuters reports » 18:14
07/29/21
07/29
18:14
07/29/21
18:14
UAL

United Airlines

$48.48 /

-0.69 (-1.40%)

United Airlines announced…

United Airlines announced it was moving forward with plans to outsource its catering operations following a six-month review, Reuters reports, citing a company memo. United said it has chosen three suppliers to operate the airline's five kitchens and oversee menu design and administration. United expects to initiate the transition in October, when federal payroll aid that prohibited airline job cuts expires, and be working with its new partners by mid-November. Reference Link

ShowHide Related Items >><<
UAL United Airlines
$48.48 /

-0.69 (-1.40%)

UAL United Airlines
$48.48 /

-0.69 (-1.40%)

07/22/21 MKM Partners
United Airlines price target lowered to $61 from $65 at MKM Partners
07/22/21 Susquehanna
United Airlines price target lowered to $51 from $56 at Susquehanna
07/13/21
Fly Intel: Top five analyst downgrades
07/13/21 Wolfe Research
Boeing upgraded to Peer Perform at Wolfe Research after United's big order
UAL United Airlines
$48.48 /

-0.69 (-1.40%)

UAL United Airlines
$48.48 /

-0.69 (-1.40%)

UAL United Airlines
$48.48 /

-0.69 (-1.40%)

UAL United Airlines
$48.48 /

-0.69 (-1.40%)

Hot Stocks
Yamana Gold increases annual dividend by nearly 15% to 12c per share » 18:11
07/29/21
07/29
18:11
07/29/21
18:11
AUY

Yamana Gold

$4.32 /

+0.06 (+1.41%)

Yamana has increased its…

Yamana has increased its annual dividend by nearly 15% to 12c per share. Shareholders of record at the close of business on September 30 will be eligible to receive payment of an increased dividend of 3c per share on October 14. The dividend is an "eligible dividend" for Canadian tax purposes.

ShowHide Related Items >><<
AUY Yamana Gold
$4.32 /

+0.06 (+1.41%)

AUY Yamana Gold
$4.32 /

+0.06 (+1.41%)

07/16/21 National Bank
Yamana Gold price target lowered to C$7.50 from C$8 at National Bank
07/08/21 Berenberg
Yamana Gold price target raised to 560 GBp from 500 GBp at Berenberg
05/20/21 National Bank
Yamana Gold price target raised to C$8 from C$7.25 at National Bank
04/23/21 National Bank
Yamana Gold price target raised to C$7.25 from C$7 at National Bank
AUY Yamana Gold
$4.32 /

+0.06 (+1.41%)

AUY Yamana Gold
$4.32 /

+0.06 (+1.41%)

Hot Stocks
Amazon says it continues to invest in international expansion  18:06
07/29/21
07/29
18:06
07/29/21
18:06
AMZN

Amazon.com

$3,599.22 /

-33.28 (-0.92%)

 
ShowHide Related Items >><<
AMZN Amazon.com
$3,599.22 /

-33.28 (-0.92%)

AMZN Amazon.com
$3,599.22 /

-33.28 (-0.92%)

07/28/21 Wedbush
Alphabet price target raised to $3,424 from $3,127 at Wedbush
07/27/21 KeyBanc
Workday HCM rollout termination at Amazon not a competitive loss, says KeyBanc
07/26/21 Credit Suisse
Amazon.com price target raised to $4,850 from $4,000 at Credit Suisse
07/26/21 Wedbush
Wedbush expects 'Amazon-sized' tailwinds from Prime Day, COVID-19
AMZN Amazon.com
$3,599.22 /

-33.28 (-0.92%)

AMZN Amazon.com
$3,599.22 /

-33.28 (-0.92%)

AMZN Amazon.com
$3,599.22 /

-33.28 (-0.92%)

AMZN Amazon.com
$3,599.22 /

-33.28 (-0.92%)

Hot Stocks
GlaxoSmithKline announces FDA approval for Nucala » 18:04
07/29/21
07/29
18:04
07/29/21
18:04
GSK

GlaxoSmithKline

$40.11 /

+0.635 (+1.61%)

GlaxoSmithKline announced…

GlaxoSmithKline announced that the U.S. FDA has approved Nucala, a monoclonal antibody that targets interleukin-5 as a treatment for patients with chronic rhinosinusitis with nasal polyps. This new indication for mepolizumab is for the add-on maintenance treatment of CRSwNP in adult patients 18 years of age and older with inadequate response to nasal corticosteroids.

ShowHide Related Items >><<
GSK GlaxoSmithKline
$40.11 /

+0.635 (+1.61%)

GSK GlaxoSmithKline
$40.11 /

+0.635 (+1.61%)

07/19/21 Barclays
GlaxoSmithKline price target raised to 1,300 GBp from 1,250 GBp at Barclays
07/06/21 Morgan Stanley
GlaxoSmithKline price target raised to 1,590 GBp at Morgan Stanley
07/06/21 Citi
Alector price target raised to $43 from $31 at Citi
07/02/21 Goldman Sachs
GSK collaboration 'positive' for Alector, says Goldman Sachs
GSK GlaxoSmithKline
$40.11 /

+0.635 (+1.61%)

GSK GlaxoSmithKline
$40.11 /

+0.635 (+1.61%)

GSK GlaxoSmithKline
$40.11 /

+0.635 (+1.61%)

GSK GlaxoSmithKline
$40.11 /

+0.635 (+1.61%)

Hot Stocks
Amazon says wage pressure becoming evident » 18:00
07/29/21
07/29
18:00
07/29/21
18:00
AMZN

Amazon.com

$3,599.22 /

-33.28 (-0.92%)

Says COVID vaccines…

Says COVID vaccines negatively affected online shopping. Says counts on having more employees in Q3 and Q4. Sees wage pressure remaining for the foreseeable future.

ShowHide Related Items >><<
AMZN Amazon.com
$3,599.22 /

-33.28 (-0.92%)

AMZN Amazon.com
$3,599.22 /

-33.28 (-0.92%)

07/28/21 Wedbush
Alphabet price target raised to $3,424 from $3,127 at Wedbush
07/27/21 KeyBanc
Workday HCM rollout termination at Amazon not a competitive loss, says KeyBanc
07/26/21 Credit Suisse
Amazon.com price target raised to $4,850 from $4,000 at Credit Suisse
07/26/21 Wedbush
Wedbush expects 'Amazon-sized' tailwinds from Prime Day, COVID-19
AMZN Amazon.com
$3,599.22 /

-33.28 (-0.92%)

AMZN Amazon.com
$3,599.22 /

-33.28 (-0.92%)

AMZN Amazon.com
$3,599.22 /

-33.28 (-0.92%)

AMZN Amazon.com
$3,599.22 /

-33.28 (-0.92%)

Earnings
AptarGroup sees Q3 adjusted EPS 90c-98c, consensus $1.10 » 17:51
07/29/21
07/29
17:51
07/29/21
17:51
ATR

AptarGroup

$139.42 /

+1.79 (+1.30%)

"For the third…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ATR AptarGroup
$139.42 /

+1.79 (+1.30%)

ATR AptarGroup
$139.42 /

+1.79 (+1.30%)

04/19/21 Deutsche Bank
AptarGroup price target raised to $162 from $152 at Deutsche Bank
04/14/21 Baird
AptarGroup downgraded to Neutral at Baird
04/14/21 Baird
AptarGroup downgraded to Neutral from Outperform at Baird
01/20/21 Deutsche Bank
AptarGroup price target raised to $152 from $127 at Deutsche Bank
ATR AptarGroup
$139.42 /

+1.79 (+1.30%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.